Literature DB >> 10174315

Interferon-beta in multiple sclerosis. Can we control its costs?

T Madgwick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 10174315     DOI： 10.2165/00019053-199712040-00007

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  Interferon-beta in multiple sclerosis. Can we control its costs?

Authors:  K H Tolley; D K Whynes
Journal:  Pharmacoeconomics       Date:  1997-03       Impact factor: 4.981

2.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Authors: 
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.